Lv4
580 积分 2023-11-14 加入
A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis
4天前
已完结
Targeting IL-17 and TH17 cells in chronic inflammation
8天前
已完结
Kidney targeting peptide-modified biomimetic nanoplatforms for treatment of acute kidney injury
22天前
已完结
Pharmacokinetics, pharmacodynamics, and tolerability of JY09 in healthy Chinese subjects: A titrating, dose-escalating study
24天前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
1个月前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1个月前
已完结
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2个月前
已完结
Bispecific antibody takes a BiTE out of B cells in rheumatoid arthritis
4个月前
已完结
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
4个月前
已完结
Recent Advances of Second‐Line Targeted Biopharmaceutical Therapies in Thyroid Associated Ophthalmopathy
5个月前
已完结
皖公网安备34019202002308
